Provided by Tiger Fintech (Singapore) Pte. Ltd.

Gilead Sciences

112.49
-1.6000-1.40%
Post-market: 112.47-0.0200-0.02%17:13 EDT
Volume:7.26M
Turnover:817.92M
Market Cap:139.58B
PE:22.45
High:114.05
Open:113.45
Low:112.15
Close:114.09
52wk High:121.83
52wk Low:81.83
Shares:1.24B
Float Shares:1.24B
Volume Ratio:0.96
T/O Rate:0.59%
Dividend:3.12
Dividend Rate:2.77%
EPS(TTM):5.01
EPS(LYR):0.3849
ROE:33.40%
ROA:12.62%
PB:7.09
PE(LYR):292.24

Loading ...

Gilead Sciences Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
42 mins ago

BRIEF-Ensoma Announces $53 Million Financing to Support Key Clinical Milestones for EN-374 and Continued Development of In Vivo Hematopoietic Stem Cell Engineering Pipeline

Reuters
·
Yesterday

Ensoma : Investors Include Gilead Which Has Also Appointed an Executive to Ensoma Board of Directors as Part of Its Investment

THOMSON REUTERS
·
Yesterday

Optimistic Growth Outlook for Gilead Sciences Driven by Yeztugo’s Market Potential and CDC Endorsement

TIPRANKS
·
Yesterday

Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Sep 18

Gilead Sciences Is Maintained at Overweight by JP Morgan

Dow Jones
·
Sep 16

Buy Recommendation for Gilead Sciences Amid Strategic Positioning and Legal Developments

TIPRANKS
·
Sep 16

JPMorgan Adjusts Price Target on Gilead Sciences to $145 From $135, Maintains Overweight Rating

MT Newswires Live
·
Sep 16

Gilead Sciences Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Sep 16

Correction to Gilead Sciences Headline on Aug. 7

Dow Jones
·
Sep 15

BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EDT on 2025-09-15

Reuters
·
Sep 15

Gilead beats whistleblower lawsuit over hepatitis C drugs

Reuters
·
Sep 13

Rothschild & Co Redburn Adjusts Gilead Sciences Price Target to $143 From $136, Maintains Buy Rating

MT Newswires Live
·
Sep 12

Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Sep 12

Poland - Factors to Watch September 11

Reuters
·
Sep 11

BRIEF-Veeva Systems Says Gilead Sciences Commits To Veeva Vault CRM

Reuters
·
Sep 10

Veeva Systems Expands Partnership With Gilead Sciences

MT Newswires Live
·
Sep 10

Gilead Sciences Selects Veeva Vault CRM for Enhanced Commercial Execution

Reuters
·
Sep 10

Gilead Sciences Commits to Veeva Vault Crm

THOMSON REUTERS
·
Sep 10

Xilio Therapeutics Extends Cash Runway into Q1 2027 Following $17.5 Million Milestone Achievement

Reuters
·
Sep 09